MET and ALK as Targets for the Treatment of NSCLC

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|20|24|3914-3932

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.20, Iss.24, 2014-05, pp. : 3914-3932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract